Mr. Riaz Bandali reports

EMERALD HEALTH THERAPEUTICS JOINT VENTURE PURE SUNFARMS LAUNCHES BRANDED PRODUCT LINE, INTRODUCING EIGHT PRODUCTS FOR THE RECREATIONAL MARKET, AND BEGINS SHIPPING TO ONTARIO CANNABIS STORE

Emerald Health Therapeutics Inc.'s 50-per-cent-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms (PSF), has formally launched its Pure Sunfarms-branded products and has introduced eight strains of dried cannabis flower for the Canadian recreational market. It has also begun shipping branded dried cannabis products to the Ontario Cannabis Store (OCS) for retail sale in Ontario. PSF expects its first products to be available at licensed retailers in Ontario and through the OCS website this month.

"Introducing the Pure Sunfarms brand today to Canadians is a culmination of our team's efforts, and we hope consumers see the passion and care our people have worked hard to bring to life," said Mandesh Dosanjh, president and chief executive officer, Pure Sunfarms. "British Columbia has a reputation for growing some of the best cannabis in the world, and we are proud to introduce a suite of products, which will continue to celebrate this legacy. Our scale, along with the team's deep agricultural roots and steadfast dedication to craftmanship, has allowed us to cultivate great-quality products at an approachable price point. In this evolving industry, we hope Canadians will come to know the quality and consistency of Pure Sunfarms' products and love it as much as we do."

The Pure Sunfarms brand was built around the philosophy of plants and people first, expressing a long-standing relationship and deep appreciation for cannabis across Canada's West Coast. It was designed to reflect the team's unique and diverse agricultural experience, sharing the story of cannabis from a different perspective. This new brand effectively leverages its high-quality product with Pure Sunfarms' low-cost production capability.

"Bringing its first selection of branded products to the recreational market represents another important milestone for Pure Sunfarms," said Riaz Bandali, chief executive officer of Emerald. "Given Pure Sunfarms' expected full run-rate production to expand to 150,000 kilograms by the end of next year, and now with the rollout of its brand strategy, PSF is well positioned to bring to market cannabis products with higher-margin sales that meet the needs of consumers."

In addition to Ontario, Pure Sunfarms expects its first products to be available at licensed retailers and on-line in British Columbia in the coming weeks.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a Canadian licensed producer of cannabis products, with strategic initiatives focused on differentiated, value-added product development for medical and adult-use customers supported by novel intellectual property, large-scale cultivation, extraction and soft gel encapsulation, as well as unique marketing and distribution channels. Its 50-per-cent-owned Pure Sunfarms operation in British Columbia has reached its full run-rate annual production of approximately 75,000 kilograms in its first 1.1-million-square-foot greenhouse Delta 3 operation, and its second 1.1-million-square-foot greenhouse is planned to be in full production by the end of 2020. Emerald's two wholly owned facilities in Quebec, a high-quality indoor growing and processing facility, and in British Columbia, an organic greenhouse and outdoor operation, are completing construction and are working toward final licensing extension. Emerald has also contracted for approximately 1,000 acres of hemp annually in 2019 to 2022 with the objective of extracting low-cost CBD (cannabidiol).

We seek Safe Harbor.